Universal Cancer Technologies - Accelerating Cancer Detection

Accelerating Cancer Detection

UCT Brief Overview 2022

20

Dec

Date December 20, 2022

Categories Presentations

See presentation for details

Author universal

The Challenge of Early-stage Cancer Detection Authors: J Tcherkassova, S Tsurkan, E Klinski and Ricardo Moro UCM Technologies Inc., Toronto, ON, Canada, UCT Research & Development Inc., Toronto, ON, Canada, Pacific Biosciences Research Center, Vancouver, BC, Canada, UCM Technologies Inc., Toronto, ON, CanadaJuly 31, 2024
ASCO 2024: ‘CA-62: A new biomarker for the detection of early-stage renal carcinoma’ posterpresentation.July 23, 2024
A novel three-biomarker signature (CA-62, CEA, CYFRA 21-1)and early-stage NSC lung cancer detection.June 3, 2023
UCT Brief Overview 2022December 20, 2022
UCT Enters into the National Phase of Patent Application in EU and IndiaDecember 1, 2022

800 Petrolia Road, Unit 3
Toronto, ON M3J 3K4
Canada
T/ 416-661-7890
E/ [email protected]